Low S-adenosylmethionine/ S-adenosylhomocysteine Ratio in Urine is Associated with Chronic Kidney Disease

Lab Med. 2020 Jan 2;51(1):80-85. doi: 10.1093/labmed/lmz035.

Abstract

Objective: To evaluate the association of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in urine with chronic kidney disease (CKD).

Methods: Case-control study including 50 patients with CKD and 20 healthy volunteers.

Results: SAM level and SAM/SAH ratio in urine were significantly lower in patients than in control individuals (P <.001 and P = .01, respectively). The estimated glomerular filtration rate was associated with the SAM level (P = .04) and the SAM/SAH ratio in urine (P = .01).

Conclusion: CKD is associated not only with the decline in the SAM level but also with the decrease in the SAM/SAH ratio in urine. Thus, use of the urinary SAM/SAH ratio as a noninvasive diagnostic indicator of renal function seems promising.

Keywords: S-adenosylhomocysteine; S-adenosylmethionine; chronic kidney disease; homocysteine; hyperhomocysteinemia; urine.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / urine
  • Female
  • Humans
  • Male
  • Middle Aged
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / urine*
  • S-Adenosylhomocysteine / urine*
  • S-Adenosylmethionine / urine*

Substances

  • Biomarkers
  • S-Adenosylmethionine
  • S-Adenosylhomocysteine